Presentation by Professor Curtis on the status (as of Dec 2020) for the mRNA COVID-19 vaccines from the perspective of Biochemical Production and distribution. The GOAL of this VIDEO is to try to convey the breadth and diversity of 'support' that is behind the expedited launch of vaccines.
In addition to the spike protein modified mRNA sequence to make the virus spike protein, this includes an examination of the liposome delivery lipids and other components of the vaccine.
Other vaccine candidates are enumerated as well as reference to contract manufacturing.
The Powerpoint slide is available here: [ Ссылка ]
